Rob Eberschlag is a Partner at WeirFoulds LLP with a practice that is focused on corporate, commercial and securities law.
Rob has 19 years of experience advising clients on corporate finance, mergers and acquisitions, joint ventures, divestitures, investment funds and corporate governance and compliance matters.
His number one priority is helping his clients navigate complex and ever-changing nature of securities law. Rob has a knack for taking highly technical and complex information and presenting it to his clients in a plain and easy to understand way.
He represents public companies and their financiers and has been involved in numerous stock exchange listings on the TSX, TSX Venture Exchange and the Canadian Stock Exchange through initial public offerings and reverse take-overs, including Capital Pool Company qualifying transactions. He has also been involved in the establishment of a number of natural resources investment funds. His sector experience includes transactions involving mining, life sciences, blockchain, renewable energy, cleantech, impact investing, oil/gas and innovation clients, including a number of significant international mandates.
Antibe Therapeutics Inc. in a $5.75-million bought deal public offering of 23,000,000 units of the Company at a price of $0.25 per Unit. February 2019.
Pelangio Exploration in a non-brokered $750,000 private placement. January 2019.
Pelangio Exploration in its acquisition of 2522962 Ontario Inc. (5SD Capital), a private company engaged in the trading and exploring of Canadian mineral properties. December 2018.
Pelangio Exploration in a non-brokered $1,200,000 private placement of units. January 2018.
Kontrol Energy Corp. in its acquisition of Efficiency Engineering Inc., a provider of detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies to industrial, municipal and commercial building owners across Canada. September 2017.
Pelangio Exploration in a non-brokered $580,000 private placement of units. August 2017.
Antibe Therapeutics Inc. a diversified biotechnology company, in connection with Antibe’s marketed $5-million public offering of units by way of a short-form prospectus. August 2017.
RJK Explorations Ltd. in connection with its sale to New Gold Inc. of all of its interest in three properties located in the Blackwater Gold District in British Columbia for total cash consideration of $1 million. July 2017.
Canadian Orebodies Inc. in connection with its entry into an agreement to acquire up to a 100% interest in the Black Raven Property near Marathon, Ontario, in the northwest portion of the Hemlo Greenstone Belt. June 2017.
Kernaghan & Partners Ltd. as agent, in connection with Liberty Biopharma Inc.’s marketed public offering of units by way of short-form prospectus. June 2017.
RJK Explorations Ltd. in connection with its non-brokered private placement of units. April 2017.
Antibe Therapeutics Inc. in its private placement of units consisting of brokered and non-brokered components, raising gross proceeds of $2.4 million. December 2016.
Kontrol Energy Corp. in its acquisition of Log-One Ltd.’s Energy Management System, an intelligent, occupancy-based heating and air-conditioning control product, including hardware, software, intellectual property and patents. December 2016.
Kontrol Energy Corp. in its private placement of units via offering memorandum, each Unit consisting of a $1,000 principal amount 8% unsecured non-convertible debenture and 100 common shares. October 2016.
Canadian Orebodies Inc. in connection with its entry into an option agreement with All-Terrain Track Sales & Services to acquire a 100% interest in 251 mineral claims located 15 kilometres northeast of Marathon, ON, and generally referred to as the “Wire Lake Property”. October 2016.
Kontrol Energy Corp. in connection with its non-brokered private placement of 1,600,000 Units, each Unit consisting of one common share and one-half of one common share purchase warrant. September 2016.
Canadian Orebodies Inc. in its non-brokered private placement of units. The financing raised gross proceeds of $5,757,480 through the sale of 95,957,999 Units. August 2016.
RJK Explorations Ltd. in connection with its non-brokered private placement of units, raising gross proceeds of $575,000. August 2016.
Nuvo Energy Grid Inc. in connection with its reverse take-over transaction with Arrowhead Gold Inc. to create Kontrol Energy Corp. and its listing on the CSE. August 2016.
Antibe Therapeutics in its $1.75 million non-brokered private placement of 4,865,000 Units, each unit consisting of one common share and one-half of one common share purchase warrant. June 2016.
Repeatedly recognized in the Canadian Legal Lexpert Directory for Mining (2015, 2016 and 2018)
Peer ranked “AV Preeminent” in 2016, 2017, 2018 and 2019 by Martindale-Hubbell Peer Review (Martindale’s highest ranking)
Member of the Investment Committee of The Atmospheric Fund
Lexis Practice Advisor Canada module on joint ventures (co-author)
“Financing and Other Exploration, Development and Production Considerations” (co-author), chapter in American Law of Mining, 2nd ed., The Rocky Mountain Mineral Law Foundation, LexisNexis Matthew Bender
“New Prospectus Exemptions for Issuers” (co-author), CIM Bulletin, November 2005
“Culture Clash: Canadian Periodical Policies and the WTO,” Manitoba Law Journal, 26, p. 65-96, 1999
Called to the Bar
- Ontario, 2000
- University of Victoria LL.B. 1998
- Dalhousie University M.A 1994
- Queen's University B.A. 1993 Hons.